| Filed On | Filing |
|---|---|
| 13 Mar 2020 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying financial statements of Arthrosurface, Inc., which comprise the balance sheets as of December 31, 2018 and 2017, and the related statements of operations, redeemable convertible preferred stock and stockh... |
| 13 Mar 2020 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Parcus Medical, LLC (the Company) as of September 30, 2019 and December 31, 2018 and the related statements of operations, changes in members' equity, and cash flows for the nine month p... |
| 05 May 2017 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read the statements made by Anika Therapeutics, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Anika Therapeutics... |
| 15 Mar 2010 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Fidia Advanced Biopolymers S.r.l. (the Company) as of December 31, 2008 and 2007, and the related statements of operations and statements of cash flows for the years then ended. These fi... |
| 22 Jul 2002 |
8-K/A: Changes in Registrant's Certifying Accountant
On July 16, 2002 Anika Therapeutics, Inc. (the "Company") engaged PricewaterhouseCoopers LLP as its principal independent auditor for the fiscal year ending December 31, 2002. Arthur Andersen LLP served as the Company's principal indepen... |
| 20 Jun 2002 |
8-K/A: Changes in Registrant's Certifying Accountant
Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Fax Number: (202) 942-9656 |
| 28 May 1998 |
8-K/A: Changes in Registrant's Certifying Accountant
COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS, INC. CENTRAL INDEX KEY: STANDARD INDUSTRIAL CLASSIFICATION: IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 |
Loading...